Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1020

1.

Extending Visit Intervals for Clinically Stable Patients on Antiretroviral Therapy: Multicohort Analysis of HIV Programs in Southern Africa.

Haas AD, Johnson LF, Grimsrud A, Ford N, Mugglin C, Fox MP, Euvrard J, van Lettow M, Prozesky H, Sikazwe I, Chimbetete C, Hobbins M, Kunzekwenyika C, Egger M; for IeDEA Southern Africa.

J Acquir Immune Defic Syndr. 2019 Aug 1;81(4):439-447. doi: 10.1097/QAI.0000000000002060.

PMID:
31242142
2.

Bridging the gap between HIV epidemiology and antiretroviral resistance evolution: Modelling the spread of resistance in South Africa.

Hauser A, Kusejko K, Johnson LF, Wandeler G, Riou J, Goldstein F, Egger M, Kouyos RD.

PLoS Comput Biol. 2019 Jun 24;15(6):e1007083. doi: 10.1371/journal.pcbi.1007083. eCollection 2019 Jun.

3.

Cervical cancer risk in women living with HIV across four continents: A multicohort study.

Rohner E, Bütikofer L, Schmidlin K, Sengayi M, Maskew M, Giddy J, Taghavi K, Moore RD, Goedert JJ, Gill MJ, Silverberg MJ, D'Souza G, Patel P, Castilho JL, Ross J, Sohn A, Bani-Sadr F, Taylor N, Paparizos V, Bonnet F, Verbon A, Vehreschild JJ, Post FA, Sabin C, Mocroft A, Dronda F, Obel N, Grabar S, Spagnuolo V, Quiros-Roldan E, Mussini C, Miro JM, Meyer L, Hasse B, Konopnicki D, Roca B, Barger D, Clifford GM, Franceschi S, Egger M, Bohlius J.

Int J Cancer. 2019 Jun 19. doi: 10.1002/ijc.32260. [Epub ahead of print]

PMID:
31215037
4.

Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis.

Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M, Salanti G.

Lancet Psychiatry. 2019 Jul;6(7):601-609. doi: 10.1016/S2215-0366(19)30217-2. Epub 2019 Jun 6.

5.

Synthesizing existing evidence to design future trials: survey of methodologists from European institutions.

Nikolakopoulou A, Trelle S, Sutton AJ, Egger M, Salanti G.

Trials. 2019 Jun 7;20(1):334. doi: 10.1186/s13063-019-3449-6.

6.

Droplet precautions on site instead of single room isolation for respiratory tract infections.

Sommerstein R, Castro Lopes Azevedo T, Aerschmann C, Hobi F, Egger M, Marschall J.

Infect Control Hosp Epidemiol. 2019 Aug;40(8):939-942. doi: 10.1017/ice.2019.142. Epub 2019 Jun 6.

PMID:
31169479
7.

Blacklists and Whitelists To Tackle Predatory Publishing: a Cross-Sectional Comparison and Thematic Analysis.

Strinzel M, Severin A, Milzow K, Egger M.

MBio. 2019 Jun 4;10(3). pii: e00411-19. doi: 10.1128/mBio.00411-19.

8.

Pelvic Floor Sensations After the First Vaginal Delivery: A Qualitative Study.

Egger MJ, Sanchez-Birkhead AC, Clark L, Curiel R, Garcia G, Fernandez C, Nygaard IE.

Female Pelvic Med Reconstr Surg. 2019 May 28. doi: 10.1097/SPV.0000000000000742. [Epub ahead of print]

PMID:
31145228
9.

Comparing the efficacy of initial percutaneous transhepatic biliary drainage and endoscopic retrograde cholangiopancreatography with stenting for relief of biliary obstruction in unresectable cholangiocarcinoma.

O'Brien S, Bhutiani N, Egger ME, Brown AN, Weaver KH, Kline D, Kelly LR, Scoggins CR, Martin RCG 2nd, Vitale GC.

Surg Endosc. 2019 May 28. doi: 10.1007/s00464-019-06871-2. [Epub ahead of print]

PMID:
31139984
10.

Light chain myeloma with bar-shaped intranuclear kappa light chain inclusions.

Egger M, Maier E, Robier C.

Ann Hematol. 2019 May 21. doi: 10.1007/s00277-019-03718-7. [Epub ahead of print] No abstract available.

PMID:
31115594
11.

The burden of cancers associated with HIV in the South African public health sector, 2004-2014: a record linkage study.

Dhokotera T, Bohlius J, Spoerri A, Egger M, Ncayiyana J, Olago V, Singh E, Sengayi M.

Infect Agent Cancer. 2019 May 3;14:12. doi: 10.1186/s13027-019-0228-7. eCollection 2019.

12.

Pulmonary arterial pressure at rest and during exercise in chronic mountain sickness: a meta-analysis.

Soria R, Egger M, Scherrer U, Bender N, Rimoldi SF.

Eur Respir J. 2019 Jun 27;53(6). pii: 1802040. doi: 10.1183/13993003.02040-2018. Print 2019 Jun.

PMID:
31023845
13.

Reply.

Dieplinger B, Egger M, Haltmayer M, Mueller T, Luft C, Hinterreiter F, Pernerstorfer T.

J Vasc Surg. 2019 May;69(5):1651-1652. doi: 10.1016/j.jvs.2019.01.023. No abstract available.

PMID:
31010528
14.

Network meta-analysis of rare events using the Mantel-Haenszel method.

Efthimiou O, Rücker G, Schwarzer G, Higgins JPT, Egger M, Salanti G.

Stat Med. 2019 Jul 20;38(16):2992-3012. doi: 10.1002/sim.8158. Epub 2019 Apr 17.

PMID:
30997687
15.

Virologic failure and HIV drug resistance on simplified, dolutegravir-based maintenance therapy: Systematic review and meta-analysis.

Wandeler G, Buzzi M, Anderegg N, Sculier D, Béguelin C, Egger M, Calmy A.

Version 2. F1000Res. 2018 Aug 30 [revised 2019 Jan 1];7:1359. doi: 10.12688/f1000research.15995.2. eCollection 2018.

16.

Trajectories of lower back, upper back, and pelvic girdle pain during pregnancy and early postpartum in primiparous women.

Dunn G, Egger MJ, Shaw JM, Yang J, Bardsley T, Powers E, Nygaard IE.

Womens Health (Lond). 2019 Jan-Dec;15:1745506519842757. doi: 10.1177/1745506519842757.

17.

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.

Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, Kopp HG, Mayer F, Haag GM, Luley K, Lindig U, Schmiegel W, Pohl M, Stoehlmacher J, Folprecht G, Probst S, Prasnikar N, Fischbach W, Mahlberg R, Trojan J, Koenigsmann M, Martens UM, Thuss-Patience P, Egger M, Block A, Heinemann V, Illerhaus G, Moehler M, Schenk M, Kullmann F, Behringer DM, Heike M, Pink D, Teschendorf C, Löhr C, Bernhard H, Schuch G, Rethwisch V, von Weikersthal LF, Hartmann JT, Kneba M, Daum S, Schulmann K, Weniger J, Belle S, Gaiser T, Oduncu FS, Güntner M, Hozaeel W, Reichart A, Jäger E, Kraus T, Mönig S, Bechstein WO, Schuler M, Schmalenberg H, Hofheinz RD; FLOT4-AIO Investigators.

Lancet. 2019 May 11;393(10184):1948-1957. doi: 10.1016/S0140-6736(18)32557-1. Epub 2019 Apr 11.

PMID:
30982686
18.

Characterization of HCC Mouse Models: Towards an Etiology-Oriented Subtyping Approach.

Friemel J, Frick L, Unger K, Egger M, Parrotta R, Böge YT, Adili A, Karin M, Luedde T, Heikenwalder M, Weber A.

Mol Cancer Res. 2019 Jul;17(7):1493-1502. doi: 10.1158/1541-7786.MCR-18-1045. Epub 2019 Apr 9.

PMID:
30967480
19.

Towards Decoding Selective Attention from Single-Trial EEG Data in Cochlear Implant Users.

Nogueira W, Cosatti G, Schierholz I, Egger M, Mirkovic B, Buchner A.

IEEE Trans Biomed Eng. 2019 Mar 26. doi: 10.1109/TBME.2019.2907638. [Epub ahead of print]

PMID:
30932825
20.

Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals.

Caniglia EC, Robins JM, Cain LE, Sabin C, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage Iii GR, Bonnet F, Le Marec F, Moore RD, Reiss P, van Sighem A, Mathews WC, Jarrín I, Alejos B, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Gill J, Pacheco A, Grinsztejn B, Napravnik S, Jose S, Phillips A, Justice A, Tate J, Bucher HC, Egger M, Furrer H, Miro JM, Casabona J, Porter K, Touloumi G, Crane H, Costagliola D, Saag M, Hernán MA.

Stat Med. 2019 Jun 15;38(13):2428-2446. doi: 10.1002/sim.8120. Epub 2019 Mar 18.

PMID:
30883859
21.

What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies.

Patten G, Schomaker M, Davies MA, Rabie H, van Zyl G, Technau K, Eley B, Boulle A, Van Dyke RB, Patel K, Sipambo N, Wood R, Tanser F, Giddy J, Cotton M, Nuttall J, Essack G, Karalius B, Seage G, Sawry S, Egger M, Fairlie L; for IeDEA Southern Africa.

Pediatr Infect Dis J. 2019 Apr;38(4):400-405. doi: 10.1097/INF.0000000000002156.

PMID:
30882732
22.

Identifying risk factor for development of perioperative venous thromboembolism in patients with gastrointestinal malignancy.

Bhutiani N, Quinn SA, Mercer MK, Hong YK, Stevenson M, Egger ME, Philips P, McMasters KM, Martin RCG 2nd, Scoggins CR.

Am J Surg. 2019 Aug;218(2):311-314. doi: 10.1016/j.amjsurg.2019.02.008. Epub 2019 Feb 12.

PMID:
30795857
23.

COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology.

Dekkers OM, Vandenbroucke JP, Cevallos M, Renehan AG, Altman DG, Egger M.

PLoS Med. 2019 Feb 21;16(2):e1002742. doi: 10.1371/journal.pmed.1002742. eCollection 2019 Feb.

24.

Compliance with wrist-worn accelerometers in primiparous early postpartum women.

Wolpern AE, Sherwin KJ, Moss WD, Nygaard IE, Egger MJ, Brusseau TA, Shaw JM.

Heliyon. 2019 Jan 31;5(1):e01193. doi: 10.1016/j.heliyon.2019.e01193. eCollection 2019 Jan.

25.

Effectiveness of 80% vs 30-35% fraction of inspired oxygen in patients undergoing surgery: an updated systematic review and meta-analysis.

de Jonge S, Egger M, Latif A, Loke YK, Berenholtz S, Boermeester M, Allegranzi B, Solomkin J.

Br J Anaesth. 2019 Mar;122(3):325-334. doi: 10.1016/j.bja.2018.11.024. Epub 2019 Jan 6.

PMID:
30770050
26.

Safety of 80% vs 30-35% fraction of inspired oxygen in patients undergoing surgery: a systematic review and meta-analysis.

Mattishent K, Thavarajah M, Sinha A, Peel A, Egger M, Solomkin J, de Jonge S, Latif A, Berenholtz S, Allegranzi B, Loke YK.

Br J Anaesth. 2019 Mar;122(3):311-324. doi: 10.1016/j.bja.2018.11.026. Epub 2019 Jan 3.

PMID:
30770049
27.

Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study.

Zürcher K, Ballif M, Fenner L, Borrell S, Keller PM, Gnokoro J, Marcy O, Yotebieng M, Diero L, Carter EJ, Rockwood N, Wilkinson RJ, Cox H, Ezati N, Abimiku AG, Collantes J, Avihingsanon A, Kawkitinarong K, Reinhard M, Hömke R, Huebner R, Gagneux S, Böttger EC, Egger M; International epidemiology Databases to Evaluate AIDS (IeDEA) consortium.

Lancet Infect Dis. 2019 Mar;19(3):298-307. doi: 10.1016/S1473-3099(18)30673-X. Epub 2019 Feb 8.

28.

Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis.

Gygli SM, Keller PM, Ballif M, Blöchliger N, Hömke R, Reinhard M, Loiseau C, Ritter C, Sander P, Borrell S, Collantes Loo J, Avihingsanon A, Gnokoro J, Yotebieng M, Egger M, Gagneux S, Böttger EC.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02175-18. doi: 10.1128/AAC.02175-18. Print 2019 Apr.

29.

Trends in influenza vaccination uptake in Switzerland: Swiss Health Survey 2007 and 2012.

Zürcher K, Zwahlen M, Berlin C, Egger M, Fenner L.

Swiss Med Wkly. 2019 Jan 23;149:w14705. doi: 10.4414/smw.2019.14705. eCollection 2019 Jan 14.

30.

Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8th Edition American Joint Committee on Cancer Staging System?

Egger ME, Stevenson M, Bhutiani N, Jordan AC, Scoggins CR, Philips P, Martin RC 2nd, McMasters KM.

J Am Coll Surg. 2019 Apr;228(4):466-472. doi: 10.1016/j.jamcollsurg.2018.12.030. Epub 2019 Jan 17.

PMID:
30660817
31.

Automatic Detection and Classification of Ca2+ Release Events in Line- and Frame-Scan Images.

Illaste A, Wullschleger M, Fernandez-Tenorio M, Niggli E, Egger M.

Biophys J. 2019 Feb 5;116(3):383-394. doi: 10.1016/j.bpj.2018.12.013. Epub 2018 Dec 25.

PMID:
30638961
32.

Prevalence of sleep-disordered breathing after stroke and TIA: A meta-analysis.

Seiler A, Camilo M, Korostovtseva L, Haynes AG, Brill AK, Horvath T, Egger M, Bassetti CL.

Neurology. 2019 Feb 12;92(7):e648-e654. doi: 10.1212/WNL.0000000000006904. Epub 2019 Jan 11.

PMID:
30635478
33.

Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation.

Panayidou K, Davies MA, Anderegg N, Egger M; IeDEA, COHERE, PHACS and IMPAACT 219C Collaborations Writing Group.

J Int AIDS Soc. 2018 Nov;21(11):e25200. doi: 10.1002/jia2.25200.

34.

High prevalence of binge drinking among people living with HIV in four African countries.

Nouaman MN, Vinikoor M, Seydi M, Ekouevi DK, Coffie PA, Mulenga L, Tanon A, Egger M, Dabis F, Jaquet A, Wandeler G; IeDEA.

J Int AIDS Soc. 2018 Dec;21(12):e25202. doi: 10.1002/jia2.25202.

35.

The use of mathematical modeling studies for evidence synthesis and guideline development: A glossary.

Porgo TV, Norris SL, Salanti G, Johnson LF, Simpson JA, Low N, Egger M, Althaus CL.

Res Synth Methods. 2019 Mar;10(1):125-133. doi: 10.1002/jrsm.1333. Epub 2019 Jan 8.

36.

HIV drug resistance in sub-Saharan Africa: public health questions and the potential role of real-world data and mathematical modelling.

de Waal R, Lessells R, Hauser A, Kouyos R, Davies MA, Egger M, Wandeler G.

J Virus Erad. 2018 Nov 15;4(Suppl 2):55-58.

37.

IeDEA-WHO Research-Policy Collaboration: contributing real-world evidence to HIV progress reporting and guideline development.

Zaniewski E, Tymejczyk O, Kariminia A, Desmonde S, Leroy V, Ford N, Sohn AH, Nash D, Yotebieng M, Cornell M, Althoff KN, Rebeiro PF, Egger M.

J Virus Erad. 2018 Nov 15;4(Suppl 2):9-15.

38.

The contribution of observational studies in supporting the WHO 'treat all' recommendation for HIV/AIDS.

Ford N, Penazzato M, Vitoria M, Doherty M, Davies MA, Zaniewski E, Tymejczyk O, Egger M, Nash D.

J Virus Erad. 2018 Nov 15;4(Suppl 2):5-8.

39.

Inactivation of sphingosine-1-phosphate receptor 2 (S1PR2) decreases demyelination and enhances remyelination in animal models of multiple sclerosis.

Seyedsadr MS, Weinmann O, Amorim A, Ineichen BV, Egger M, Mirnajafi-Zadeh J, Becher B, Javan M, Schwab ME.

Neurobiol Dis. 2019 Apr;124:189-201. doi: 10.1016/j.nbd.2018.11.018. Epub 2018 Nov 22.

PMID:
30468865
40.

Challenges in assessing the sunscreen-melanoma association.

Rueegg CS, Stenehjem JS, Egger M, Ghiasvand R, Cho E, Lund E, Weiderpass E, Green AC, Veierød MB.

Int J Cancer. 2019 Jun 1;144(11):2651-2668. doi: 10.1002/ijc.31997. Epub 2019 Jan 7.

41.

Estimating the contribution of studies in network meta-analysis: paths, flows and streams.

Papakonstantinou T, Nikolakopoulou A, Rücker G, Chaimani A, Schwarzer G, Egger M, Salanti G.

Version 2. F1000Res. 2018 May 18 [revised 2018 Jan 1];7:610. doi: 10.12688/f1000research.14770.2. eCollection 2018.

42.

ASO Author Reflections: The Sentinel Lymph Node in Melanoma: Now More Important Than Ever.

Egger ME, McMasters KM.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):906-907. doi: 10.1245/s10434-018-6855-1. Epub 2018 Oct 11. No abstract available.

PMID:
30311165
43.

A model for predicting low probability of nonsentinel lymph node positivity in melanoma patients with a single positive sentinel lymph node.

Bhutiani N, Egger ME, Stromberg AJ, Gershenwald JE, Ross MI, Philips P, Martin RCG 2nd, Scoggins CR, McMasters KM.

J Surg Oncol. 2018 Nov;118(6):922-927. doi: 10.1002/jso.25193. Epub 2018 Sep 27.

PMID:
30259521
44.

Ductal carcinoma in situ current trends, controversies, and review of literature.

Hong YK, McMasters KM, Egger ME, Ajkay N.

Am J Surg. 2018 Nov;216(5):998-1003. doi: 10.1016/j.amjsurg.2018.06.013. Epub 2018 Jun 18. Review.

PMID:
30244816
45.

Evaluation of sex-specific cut-off values of high-sensitivity cardiac troponin I and T assays in an emergency department setting - Results from the Linz Troponin (LITROP) study.

Mueller T, Egger M, Peer E, Jani E, Dieplinger B.

Clin Chim Acta. 2018 Dec;487:66-74. doi: 10.1016/j.cca.2018.09.026. Epub 2018 Sep 15.

PMID:
30227114
46.

Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid Arthritis.

Didden EM, Ruffieux Y, Hummel N, Efthimiou O, Reichenbach S, Gsteiger S, Finckh A, Fletcher C, Salanti G, Egger M; IMI GetReal Work Package 4.

Med Decis Making. 2018 Aug;38(6):719-729. doi: 10.1177/0272989X18775975.

PMID:
30074882
47.

Safety and efficacy of irreversible electroporation in the treatment of obstructive jaundice in advanced hilar cholangiocarcinoma.

Martin EK, Bhutiani N, Egger ME, Philips P, Scoggins CR, McMasters KM, Kelly LR, Vitale GC, Martin RCG.

HPB (Oxford). 2018 Nov;20(11):1092-1097. doi: 10.1016/j.hpb.2018.06.1806. Epub 2018 Jul 26.

PMID:
30057125
48.

Atypical "hairy cell-like" presentation of leukemic mantle cell lymphoma.

Robier C, Hoefler G, Egger M, Hubmann E.

Clin Chem Lab Med. 2018 Dec 19;57(2):e34-e36. doi: 10.1515/cclm-2018-0633. No abstract available.

PMID:
30032129
49.

Obstruction of ventricular Ca2+ -dependent arrhythmogenicity by inositol 1,4,5-trisphosphate-triggered sarcoplasmic reticulum Ca2+ release.

Blanch I Salvador J, Egger M.

J Physiol. 2018 Sep;596(18):4323-4340. doi: 10.1113/JP276319. Epub 2018 Aug 7.

PMID:
30004117
50.

Planning a future randomized clinical trial based on a network of relevant past trials.

Salanti G, Nikolakopoulou A, Sutton AJ, Reichenbach S, Trelle S, Naci H, Egger M.

Trials. 2018 Jul 11;19(1):365. doi: 10.1186/s13063-018-2740-2.

Supplemental Content

Support Center